Earnings History Data for Viracta Therapeutics (VIRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Viracta Therapeutics
Viracta Therapeutics Inc. is a precision oncology company targeting virus-associated malignancies. The company is pursuing application of inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma and other virus-related cancers. Viracta Therapeutics Inc., formerly known as Sunesis Pharmaceuticals Inc., is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | AH | VIRX | Viracta Therapeutics | 37.00 | -0.35 | -0.30 | 0.00 | Viracta Therapeutics GAAP EPS of -$0.35 misses by $0.04 [3/7/2024 5:29 PM] |
0.8550 | 0.04 (5.54%) |
0.88 | 0.07 (8.12%) |
0.43 - 2.38 | 215,454 | 120,000 | 19,721 | ||
| 14-08-2023 | PM | VIRX | Viracta Therapeutics | 55.00 | -0.32 | -0.30 | 0.00 | Viracta Therapeutics GAAP EPS of -$0.32 [8/14/2023 9:18 AM] |
1.39 | -0.05 (-3.47%) |
0.0 | 0.0 (0.00%) |
0.88 - 5.75 | 46,195 | 80,000 | 0 | ||
| 08-05-2023 | AH | 4:05 PM ET (May 8) |
VIRX | Viracta Therapeutics | 43.00 | -0.32 | -0.31 | 0.00 | Viracta Therapeutics GAAP EPS of -$0.32 [5/8/2023 5:13 PM] |
1.03 | 0.14 (16.02%) |
0.0 | 0.0 (0.00%) |
0.88 - 5.75 | 219,133 | 110,000 | 0 | |
| 13-03-2023 | AH | VIRX | Viracta Therapeutics | 65.00 | -0.27 | -0.40 | 0.00 | Viracta Therapeutics GAAP EPS of -$0.27 beats by $0.12 [3/13/2023 4:50 PM] |
1.75 | 0.05 (2.94%) |
1.92 | 0.22 (12.94%) |
1.21 - 5.75 | 55,109 | 50,000 | 2,402 | ||
| 09-08-2022 | PM | VIRX | Viracta Therapeutics | 145.00 | -0.28 | -0.30 | 0.00 | Viracta Therapeutics GAAP EPS of -$0.28 [8/9/2022 8:53 AM] |
3.48 | -0.47 (-11.90%) |
3.87 | -0.08 (-2.03%) |
1.82 - 11.56 | 143,805 | 90,000 | 1,200 | ||
| 10-05-2022 | AH | After the close (May 10) |
VIRX | Viracta Therapeutics, Inc. | 84.35 | -0.28 | -0.32 | 0.38 | Viracta Therapeutics GAAP EPS of -$0.28 [5/10/2022 5:33 PM] |
2.04 | -0.27 (-11.70%) |
0.0 | 0.0 (0.00%) |
2.03 - 13.08 | 179,689 | 170,000 | 0 | |
| 10-11-2021 | PM | VIRX | Viracta Therapeutics | 220.00 | -0.40 | -0.31 | 0.00 | Viracta Therapeutics EPS misses by $0.09 [11/10/2021 8:40 AM] |
5.66 | -0.26 (-4.39%) |
0.0 | 0.0 (0.00%) |
3.99 - 24.80 | 143,872 | 160,000 | 0 | ||
| 12-08-2021 | PM | VIRX | Viracta Therapeutics, Inc. | 391.00 | -0.25 | -0.24 | 0.00 | Viracta Therapeutics reports Q2 results [8/12/2021 8:43 AM] |
10.50 | 0.07 (0.67%) |
10.50 | 0.0 (0.00%) |
3.92 - 24.80 | 84,920 | 90,000 | 5,268 | ||
| 12-05-2021 | AH | VIRX | Viracta Therapeutics, Inc. | 55.00 | 0.38 | 0.02 | 0.00 | Viracta Therapeutics EPS misses by $5.24 [5/12/2021 4:40 PM] |
7.65 | -1.54 (-16.76%) |
9.19 | 0.0 (0.00%) |
3.92 - 24.80 | 539,798 | 420,000 | 209 | ||